scholarly article | Q13442814 |
P50 | author | Volkmar Falk | Q43778131 |
Benedikt Weber | Q55069736 | ||
Marisa Jaconi | Q63865641 | ||
P2093 | author name string | Alessandro Boni | |
Simon P Hoerstrup | |||
Alexis Bosman | |||
Chad E Brokopp | |||
Maximilian Y Emmert | |||
Petra Wolint | |||
Nadine Wickboldt | |||
Gino Gemayel | |||
P2860 | cites work | Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages | Q24310167 |
Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
Generation of germline-competent induced pluripotent stem cells | Q28131699 | ||
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts | Q29614794 | ||
RETRACTED: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial | Q29620044 | ||
P433 | issue | 27 | |
P304 | page(s) | 6339-6354 | |
P577 | publication date | 2013-05-30 | |
P1433 | published in | Biomaterials | Q15751139 |
P1476 | title | Human stem cell-based three-dimensional microtissues for advanced cardiac cell therapies | |
P478 | volume | 34 |
Q90573402 | 3D bioprinting for cardiovascular regeneration and pharmacology |
Q41509582 | Artificial Cardiac Muscle with or without the Use of Scaffolds. |
Q26799556 | Bioengineering and Stem Cell Technology in the Treatment of Congenital Heart Disease |
Q26776414 | Bioprocessing strategies for the large-scale production of human mesenchymal stem cells: a review |
Q28079057 | Cardiac Regenerative Medicine: The Potential of a New Generation of Stem Cells |
Q28067086 | Cardiovascular Regenerative Technologies: Update and Future Outlook |
Q92394704 | Cellular Therapy for Ischemic Heart Disease: An Update |
Q60948367 | Functionally Improved Mesenchymal Stem Cells to Better Treat Myocardial Infarction |
Q39360944 | In Utero Stem Cell Transplantation: Potential Therapeutic Application for Muscle Diseases. |
Q34246093 | Microscale generation of cardiospheres promotes robust enrichment of cardiomyocytes derived from human pluripotent stem cells. |
Q41108839 | Microtissues Enhance Smooth Muscle Differentiation and Cell Viability of hADSCs for Three Dimensional Bioprinting |
Q26748747 | Microtissues in Cardiovascular Medicine: Regenerative Potential Based on a 3D Microenvironment |
Q64243195 | Modelling cardiac fibrosis using three-dimensional cardiac microtissues derived from human embryonic stem cells |
Q47327449 | Morphological transformation of hBMSC from 2D monolayer to 3D microtissue on low-crystallinity SF-PCL patch with promotion of cardiomyogenesis. |
Q92994217 | Phenotypic Variation Between Stromal Cells Differentially Impacts Engineered Cardiac Tissue Function |
Q51151987 | Promoting Cardiomyogenesis of hBMSC with a Forming Self-Assembly hBMSC Microtissues/HA-GRGD/SF-PCL Cardiac Patch Is Mediated by the Synergistic Functions of HA-GRGD. |
Q38874116 | Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue. |
Q64092533 | Simultaneous blocking of CD47 and PD-L1 increases innate and adaptive cancer immune responses and cytokine release |
Q39264982 | The therapeutic potential of three-dimensional multipotent mesenchymal stromal cell spheroids |
Q96954753 | Three-Dimensional Compaction Switches Stress Response Programs and Enhances Therapeutic Efficacy of Endometrial Mesenchymal Stem/Stromal Cells |
Q34290984 | Three-dimensional aggregates of mesenchymal stem cells: cellular mechanisms, biological properties, and applications. |
Q52729630 | Translational cardiac stem cell therapy: advancing from first-generation to next-generation cell types. |
Q42498557 | Well-organized spheroids as a new platform to examine cell interaction and behaviour during organ development. |
Search more.